Finding 1151561 (2024-107)

Significant Deficiency
Requirement
B
Questioned Costs
-
Year
2024
Accepted
2025-08-28
Audit: 365222
Organization: Pancare of Florida, INC (FL)

AI Summary

  • Core Issue: An error in calculating personnel costs led to an overcharge for September 2024 reimbursements, using August wages instead.
  • Impacted Requirements: Compliance with 2 CFR section 200.303 and 200.430(g) regarding allowable costs and internal controls over federal awards.
  • Recommended Follow-up: Enhance review processes for reimbursement requests to ensure accurate allocation of costs based on the correct periods.

Finding Text

2024-107 Incorrect Costs were Submitted for Reimbursement (Initially reported 2024) Assistance Listing Number: 93.211 Name of Federal Agency: Department of Health and Human Services, HRSA Program Title: Rural Telemedicine Grants Compliance Requirement: Allowable Costs Pass-through Entity: N/A Federal Grant/Contract Number and Grant Year: GA142923 (2021), G2846293 (2022), and GA3949501 (2023) Finding Type: Significant Deficiency in Internal Control Questioned Costs: $68 known and $589 likely Condition: The September 2024 reimbursement request included one instance, out of 37 items tested, where calculations of personnel expenditures allocable to the grant used an inaccurate amount, resulting in an overcharge of personnel expenditures. In calculating the allocable expenditure, wages for the month of August, which had previously been charged to the grant, were used to calculate the amount allocable to the grant for the month of September. Gross wages for August exceeded gross wages for September. Wages for both months were allowable and allocable to the grant. This is not a systemic problem but an isolated occurrence resulting in an immaterial difference in the amount reimbursed and the amount that should have been requested for September 2024 wages paid. The sample was not statistically valid. Criteria: 2 CFR section 200.303 requires that nonfederal entities receiving federal awards establish and maintain internal control over the federal awards that provides reasonable assurance that the nonfederal entity is managing the federal awards in compliance with federal statutes, regulations, and the terms and conditions of the federal awards. Per 2 CFR 200.430(g), costs charged to federal awards must be supported by records that- support the distribution of salaries and wages among specific activities, while reflecting the total activity of the employee, not to exceed 100% of compensated activities. Cause: Wages requested for reimbursement in September 2024 reflected the wages paid in August 2024 in error and were not detected during the review process over the reimbursement request. Effect: Personnel costs charged to the award were based on amounts exceeding 100% of the employee’s compensation for one month, resulting in an overcharge to the award. Recommendation: Review of costs allocated and requested for reimbursement should incorporate consideration of the period the costs were incurred. Views of Responsible Officials and Planned Corrective Action: We acknowledge the finding and have strengthened our review process for reimbursement requests to prevent similar errors. Finance staff verify payroll periods against reimbursement periods before submission, and supervisors perform an additional review. This process includes careful cross-checking against the appropriate pay periods. This was an isolated occurrence with immaterial impact, but corrective steps will ensure accuracy in future requests.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 575077 2024-101
    Material Weakness Repeat
  • 575078 2024-104
    Significant Deficiency Repeat
  • 575079 2024-105
    Material Weakness Repeat
  • 575080 2024-106
    Material Weakness
  • 575081 2024-101
    Material Weakness Repeat
  • 575082 2024-104
    Significant Deficiency Repeat
  • 575083 2024-105
    Material Weakness Repeat
  • 575084 2024-106
    Material Weakness
  • 575085 2024-101
    Material Weakness Repeat
  • 575086 2024-104
    Significant Deficiency Repeat
  • 575087 2024-105
    Material Weakness Repeat
  • 575088 2024-106
    Material Weakness
  • 575089 2024-101
    Material Weakness Repeat
  • 575090 2024-104
    Significant Deficiency Repeat
  • 575091 2024-105
    Material Weakness Repeat
  • 575092 2024-106
    Material Weakness
  • 575093 2024-101
    Material Weakness Repeat
  • 575094 2024-104
    Significant Deficiency Repeat
  • 575095 2024-105
    Material Weakness Repeat
  • 575096 2024-106
    Material Weakness
  • 575097 2024-104
    Significant Deficiency Repeat
  • 575098 2024-101
    Material Weakness Repeat
  • 575099 2024-104
    Significant Deficiency Repeat
  • 575100 2024-105
    Material Weakness Repeat
  • 575101 2024-106
    Material Weakness
  • 575102 2024-101
    Material Weakness Repeat
  • 575103 2024-104
    Significant Deficiency Repeat
  • 575104 2024-105
    Material Weakness Repeat
  • 575105 2024-106
    Material Weakness
  • 575106 2024-101
    Material Weakness Repeat
  • 575107 2024-104
    Significant Deficiency Repeat
  • 575108 2024-105
    Material Weakness Repeat
  • 575109 2024-106
    Material Weakness
  • 575110 2024-102
    Significant Deficiency
  • 575111 2024-104
    Significant Deficiency Repeat
  • 575112 2024-105
    Material Weakness Repeat
  • 575113 2024-106
    Material Weakness
  • 575114 2024-107
    Significant Deficiency
  • 575115 2024-102
    Significant Deficiency
  • 575116 2024-104
    Significant Deficiency Repeat
  • 575117 2024-105
    Material Weakness Repeat
  • 575118 2024-106
    Material Weakness
  • 575119 2024-107
    Significant Deficiency
  • 575120 2024-104
    Significant Deficiency Repeat
  • 575121 2024-105
    Material Weakness Repeat
  • 575122 2024-106
    Material Weakness
  • 575123 2024-107
    Significant Deficiency
  • 1151519 2024-101
    Material Weakness Repeat
  • 1151520 2024-104
    Significant Deficiency Repeat
  • 1151521 2024-105
    Material Weakness Repeat
  • 1151522 2024-106
    Material Weakness
  • 1151523 2024-101
    Material Weakness Repeat
  • 1151524 2024-104
    Significant Deficiency Repeat
  • 1151525 2024-105
    Material Weakness Repeat
  • 1151526 2024-106
    Material Weakness
  • 1151527 2024-101
    Material Weakness Repeat
  • 1151528 2024-104
    Significant Deficiency Repeat
  • 1151529 2024-105
    Material Weakness Repeat
  • 1151530 2024-106
    Material Weakness
  • 1151531 2024-101
    Material Weakness Repeat
  • 1151532 2024-104
    Significant Deficiency Repeat
  • 1151533 2024-105
    Material Weakness Repeat
  • 1151534 2024-106
    Material Weakness
  • 1151535 2024-101
    Material Weakness Repeat
  • 1151536 2024-104
    Significant Deficiency Repeat
  • 1151537 2024-105
    Material Weakness Repeat
  • 1151538 2024-106
    Material Weakness
  • 1151539 2024-104
    Significant Deficiency Repeat
  • 1151540 2024-101
    Material Weakness Repeat
  • 1151541 2024-104
    Significant Deficiency Repeat
  • 1151542 2024-105
    Material Weakness Repeat
  • 1151543 2024-106
    Material Weakness
  • 1151544 2024-101
    Material Weakness Repeat
  • 1151545 2024-104
    Significant Deficiency Repeat
  • 1151546 2024-105
    Material Weakness Repeat
  • 1151547 2024-106
    Material Weakness
  • 1151548 2024-101
    Material Weakness Repeat
  • 1151549 2024-104
    Significant Deficiency Repeat
  • 1151550 2024-105
    Material Weakness Repeat
  • 1151551 2024-106
    Material Weakness
  • 1151552 2024-102
    Significant Deficiency
  • 1151553 2024-104
    Significant Deficiency Repeat
  • 1151554 2024-105
    Material Weakness Repeat
  • 1151555 2024-106
    Material Weakness
  • 1151556 2024-107
    Significant Deficiency
  • 1151557 2024-102
    Significant Deficiency
  • 1151558 2024-104
    Significant Deficiency Repeat
  • 1151559 2024-105
    Material Weakness Repeat
  • 1151560 2024-106
    Material Weakness
  • 1151562 2024-104
    Significant Deficiency Repeat
  • 1151563 2024-105
    Material Weakness Repeat
  • 1151564 2024-106
    Material Weakness
  • 1151565 2024-107
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.526 Covid-19 Grants for Capital Development in Health Centers $728,277
10.766 Community Facilities Loans and Grants $411,641
93.224 Covid-19 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $346,967
93.211 Telehealth Programs $309,134
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $275,916
93.224 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $175,931
93.939 Hiv Prevention Activities Non-Governmental Organization Based $149,480
93.527 Grants for New and Expanded Services Under the Health Center Program $121,766
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $103,014
10.855 Distance Learning and Telemedicine Loans and Grants $59,029
93.969 Pphf Geriatric Education Centers $33,933
93.527 Covid-19 Grants for New and Expanded Services Under the Health Center Program $27,500